Skip to main content
Erschienen in: European Radiology 9/2019

20.02.2019 | Gastrointestinal

Problematic lesions in cirrhotic liver mimicking hepatocellular carcinoma

verfasst von: Myeong-Jin Kim, Sunyoung Lee, Chansik An

Erschienen in: European Radiology | Ausgabe 9/2019

Einloggen, um Zugang zu erhalten

Abstract

Hepatocellular carcinoma (HCC) is a unique malignancy that can be diagnosed and treated based on non-invasive imaging criteria without histological confirmation in cirrhotic patients, which opens the possibility, although rare, of false-positive diagnosis of the tumor. This brief review illustrates benign and non-HCC malignant lesions arising in cirrhotic liver that could have been erroneously diagnosed as HCC based on imaging criteria: focal nodular hyperplasia–like nodules, serum amyloid A–positive nodules, dysplastic nodules, spontaneously regressing lesions, combined hepatocellular-cholangiocarcinoma, cholangiocarcinoma, sarcomatoid carcinoma, lymphoepithelioma-like carcinoma, hepatoblastoma, and metastatic adenocarcinoma. To determine the potential differences in clinical courses and post-treatment outcome of HCC diagnosed by imaging alone and those histologically, we suggest the terms HCCi and HCCp to distinguish between lesions that are diagnosed as HCC based on imaging alone from those diagnosed based on pathological examination, respectively.
Key Points
• Benign lesions, such as focal nodular hyperplasia–like nodules, serum amyloid A–positive nodules, dysplastic nodules, and spontaneously regressing lesions, may show imaging findings that mislead to the diagnosis of HCC.
• Non-hepatocellular malignant lesions, such as sarcomatoid carcinoma, lymphoepithelioma-like carcinoma, hepatoblastoma, and metastatic adenocarcinomas, can be erroneously diagnosed as HCC based on imaging findings alone, even in cirrhotic liver.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Kudo M, Trevisani F, Abou-Alfa GK, Rimassa L (2016) Hepatocellular carcinoma: therapeutic guidelines and medical treatment. Liver Cancer 6:16–26CrossRefPubMedPubMedCentral Kudo M, Trevisani F, Abou-Alfa GK, Rimassa L (2016) Hepatocellular carcinoma: therapeutic guidelines and medical treatment. Liver Cancer 6:16–26CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Heimbach JK, Kulik LM, Finn RS et al (2018) AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology 67:358–380CrossRefPubMed Heimbach JK, Kulik LM, Finn RS et al (2018) AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology 67:358–380CrossRefPubMed
3.
Zurück zum Zitat European Association for the Study of the Liver (2018) EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 69:182–236 European Association for the Study of the Liver (2018) EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 69:182–236
4.
Zurück zum Zitat Park HJ, Choi BI, Lee ES, Park SB, Lee JB (2017) How to differentiate borderline hepatic nodules in hepatocarcinogenesis: emphasis on imaging diagnosis. Liver Cancer 6:189–203CrossRefPubMedPubMedCentral Park HJ, Choi BI, Lee ES, Park SB, Lee JB (2017) How to differentiate borderline hepatic nodules in hepatocarcinogenesis: emphasis on imaging diagnosis. Liver Cancer 6:189–203CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Chernyak V, Fowler KJ, Kamaya A et al (2018) Liver Imaging Reporting and Data System (LI-RADS) version 2018: imaging of hepatocellular carcinoma in at-risk patients. Radiology 289:816–830CrossRefPubMed Chernyak V, Fowler KJ, Kamaya A et al (2018) Liver Imaging Reporting and Data System (LI-RADS) version 2018: imaging of hepatocellular carcinoma in at-risk patients. Radiology 289:816–830CrossRefPubMed
6.
Zurück zum Zitat Ronot M, Dioguardi Burgio M, Purcell Y, Pommier R, Brancatelli G, Vilgrain V (2017) Focal lesions in cirrhosis: not always HCC. Eur J Radiol 93:157–168CrossRefPubMed Ronot M, Dioguardi Burgio M, Purcell Y, Pommier R, Brancatelli G, Vilgrain V (2017) Focal lesions in cirrhosis: not always HCC. Eur J Radiol 93:157–168CrossRefPubMed
7.
Zurück zum Zitat Galia M, Taibbi A, Marin D et al (2014) Focal lesions in cirrhotic liver: what else beyond hepatocellular carcinoma? Diagn Interv Radiol 20:222–228CrossRefPubMedPubMedCentral Galia M, Taibbi A, Marin D et al (2014) Focal lesions in cirrhotic liver: what else beyond hepatocellular carcinoma? Diagn Interv Radiol 20:222–228CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Elsayes KM, Chernyak V, Morshid AI et al (2018) Spectrum of pitfalls, pseudolesions, and potential misdiagnoses in cirrhosis. AJR Am J Roentgenol 211:87–96CrossRefPubMed Elsayes KM, Chernyak V, Morshid AI et al (2018) Spectrum of pitfalls, pseudolesions, and potential misdiagnoses in cirrhosis. AJR Am J Roentgenol 211:87–96CrossRefPubMed
9.
Zurück zum Zitat Cruite I, Tang A, Sirlin CB (2013) Imaging-based diagnostic systems for hepatocellular carcinoma. AJR Am J Roentgenol 201:41–55CrossRefPubMed Cruite I, Tang A, Sirlin CB (2013) Imaging-based diagnostic systems for hepatocellular carcinoma. AJR Am J Roentgenol 201:41–55CrossRefPubMed
10.
Zurück zum Zitat Tang A, Bashir MR, Corwin MT et al (2018) Evidence supporting LI-RADS major features for CT- and MR imaging-based diagnosis of hepatocellular carcinoma: a systematic review. Radiology 286:29–48CrossRefPubMed Tang A, Bashir MR, Corwin MT et al (2018) Evidence supporting LI-RADS major features for CT- and MR imaging-based diagnosis of hepatocellular carcinoma: a systematic review. Radiology 286:29–48CrossRefPubMed
11.
Zurück zum Zitat Tang A, Hallouch O, Chernyak V, Kamaya A, Sirlin CB (2018) Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis. Abdom Radiol (NY) 43:13–25CrossRef Tang A, Hallouch O, Chernyak V, Kamaya A, Sirlin CB (2018) Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis. Abdom Radiol (NY) 43:13–25CrossRef
12.
Zurück zum Zitat Lee YH, Kim SH, Cho MY, Shim KY, Kim MS (2007) Focal nodular hyperplasia-like nodules in alcoholic liver cirrhosis: radiologic-pathologic correlation. AJR Am J Roentgenol 188:W459–W463CrossRefPubMed Lee YH, Kim SH, Cho MY, Shim KY, Kim MS (2007) Focal nodular hyperplasia-like nodules in alcoholic liver cirrhosis: radiologic-pathologic correlation. AJR Am J Roentgenol 188:W459–W463CrossRefPubMed
13.
Zurück zum Zitat Marin D, Galluzzo A, Plessier A, Brancatelli G, Valla D, Vilgrain V (2011) Focal nodular hyperplasia-like lesions in patients with cavernous transformation of the portal vein: prevalence, MR findings and natural history. Eur Radiol 21:2074–2082CrossRefPubMed Marin D, Galluzzo A, Plessier A, Brancatelli G, Valla D, Vilgrain V (2011) Focal nodular hyperplasia-like lesions in patients with cavernous transformation of the portal vein: prevalence, MR findings and natural history. Eur Radiol 21:2074–2082CrossRefPubMed
14.
Zurück zum Zitat Choi JY, Lee HC, Yim JH et al (2011) Focal nodular hyperplasia or focal nodular hyperplasia-like lesions of the liver: a special emphasis on diagnosis. J Gastroenterol Hepatol 26:1004–1009CrossRefPubMed Choi JY, Lee HC, Yim JH et al (2011) Focal nodular hyperplasia or focal nodular hyperplasia-like lesions of the liver: a special emphasis on diagnosis. J Gastroenterol Hepatol 26:1004–1009CrossRefPubMed
15.
Zurück zum Zitat Kim JW, Lee CH, Kim SB et al (2017) Washout appearance in Gd-EOB-DTPA-enhanced MR imaging: a differentiating feature between hepatocellular carcinoma with paradoxical uptake on the hepatobiliary phase and focal nodular hyperplasia-like nodules. J Magn Reson Imaging 45:1599–1608CrossRefPubMed Kim JW, Lee CH, Kim SB et al (2017) Washout appearance in Gd-EOB-DTPA-enhanced MR imaging: a differentiating feature between hepatocellular carcinoma with paradoxical uptake on the hepatobiliary phase and focal nodular hyperplasia-like nodules. J Magn Reson Imaging 45:1599–1608CrossRefPubMed
16.
Zurück zum Zitat Libbrecht L, Cassiman D, Verslype C et al (2006) Clinicopathological features of focal nodular hyperplasia-like nodules in 130 cirrhotic explant livers. Am J Gastroenterol 101:2341–2346CrossRefPubMed Libbrecht L, Cassiman D, Verslype C et al (2006) Clinicopathological features of focal nodular hyperplasia-like nodules in 130 cirrhotic explant livers. Am J Gastroenterol 101:2341–2346CrossRefPubMed
17.
Zurück zum Zitat Kim MJ, Rhee HJ, Jeong HT (2012) Hyperintense lesions on gadoxetate disodium-enhanced hepatobiliary phase imaging. AJR Am J Roentgenol 199:W575–W586CrossRefPubMed Kim MJ, Rhee HJ, Jeong HT (2012) Hyperintense lesions on gadoxetate disodium-enhanced hepatobiliary phase imaging. AJR Am J Roentgenol 199:W575–W586CrossRefPubMed
18.
Zurück zum Zitat Sasaki M, Yoneda N, Sawai Y et al (2015) Clinicopathological characteristics of serum amyloid A-positive hepatocellular neoplasms/nodules arising in alcoholic cirrhosis. Histopathology 66:836–845CrossRefPubMed Sasaki M, Yoneda N, Sawai Y et al (2015) Clinicopathological characteristics of serum amyloid A-positive hepatocellular neoplasms/nodules arising in alcoholic cirrhosis. Histopathology 66:836–845CrossRefPubMed
19.
Zurück zum Zitat Kim SR, Kondo F, Otono Y et al (2014) Serum amyloid A and C-reactive protein positive nodule in alcoholic liver cirrhosis, hard to make definite diagnosis. Hepatol Res 44:584–590CrossRefPubMed Kim SR, Kondo F, Otono Y et al (2014) Serum amyloid A and C-reactive protein positive nodule in alcoholic liver cirrhosis, hard to make definite diagnosis. Hepatol Res 44:584–590CrossRefPubMed
20.
Zurück zum Zitat Lim JH, Cho JM, Kim EY, Park CK (2000) Dysplastic nodules in liver cirrhosis: evaluation of hemodynamics with CT during arterial portography and CT hepatic arteriography. Radiology 214:869–874CrossRefPubMed Lim JH, Cho JM, Kim EY, Park CK (2000) Dysplastic nodules in liver cirrhosis: evaluation of hemodynamics with CT during arterial portography and CT hepatic arteriography. Radiology 214:869–874CrossRefPubMed
21.
Zurück zum Zitat Chou CT, Chou JM, Chang TA et al (2013) Differentiation between dysplastic nodule and early-stage hepatocellular carcinoma: the utility of conventional MR imaging. World J Gastroenterol 19:7433–7439CrossRefPubMedPubMedCentral Chou CT, Chou JM, Chang TA et al (2013) Differentiation between dysplastic nodule and early-stage hepatocellular carcinoma: the utility of conventional MR imaging. World J Gastroenterol 19:7433–7439CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Lim JH, Kim MJ, Park CK, Kang SS, Lee WJ, Lim HK (2004) Dysplastic nodules in liver cirrhosis: detection with triple phase helical dynamic CT. Br J Radiol 77:911–916CrossRefPubMed Lim JH, Kim MJ, Park CK, Kang SS, Lee WJ, Lim HK (2004) Dysplastic nodules in liver cirrhosis: detection with triple phase helical dynamic CT. Br J Radiol 77:911–916CrossRefPubMed
23.
Zurück zum Zitat Inchingolo R, De Gaetano AM, Curione D et al (2015) Role of diffusion-weighted imaging, apparent diffusion coefficient and correlation with hepatobiliary phase findings in the differentiation of hepatocellular carcinoma from dysplastic nodules in cirrhotic liver. Eur Radiol 25:1087–1096CrossRefPubMed Inchingolo R, De Gaetano AM, Curione D et al (2015) Role of diffusion-weighted imaging, apparent diffusion coefficient and correlation with hepatobiliary phase findings in the differentiation of hepatocellular carcinoma from dysplastic nodules in cirrhotic liver. Eur Radiol 25:1087–1096CrossRefPubMed
24.
Zurück zum Zitat Sersté T, Barrau V, Ozenne V et al (2012) Accuracy and disagreement of computed tomography and magnetic resonance imaging for the diagnosis of small hepatocellular carcinoma and dysplastic nodules: role of biopsy. Hepatology 55:800–806 Sersté T, Barrau V, Ozenne V et al (2012) Accuracy and disagreement of computed tomography and magnetic resonance imaging for the diagnosis of small hepatocellular carcinoma and dysplastic nodules: role of biopsy. Hepatology 55:800–806
26.
Zurück zum Zitat Rhee H, Kim MJ, Park MS, Kim KA (2012) Differentiation of early hepatocellular carcinoma from benign hepatocellular nodules on gadoxetic acid-enhanced MRI. Br J Radiol 85:e837–e844CrossRefPubMedPubMedCentral Rhee H, Kim MJ, Park MS, Kim KA (2012) Differentiation of early hepatocellular carcinoma from benign hepatocellular nodules on gadoxetic acid-enhanced MRI. Br J Radiol 85:e837–e844CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Kim TK, Lee KH, Jang HJ et al (2011) Analysis of gadobenate dimeglumine-enhanced MR findings for characterizing small (1-2-cm) hepatic nodules in patients at high risk for hepatocellular carcinoma. Radiology 259:730–738CrossRefPubMed Kim TK, Lee KH, Jang HJ et al (2011) Analysis of gadobenate dimeglumine-enhanced MR findings for characterizing small (1-2-cm) hepatic nodules in patients at high risk for hepatocellular carcinoma. Radiology 259:730–738CrossRefPubMed
28.
Zurück zum Zitat Renzulli M, Biselli M, Brocchi S et al (2018) New hallmark of hepatocellular carcinoma, early hepatocellular carcinoma and high-grade dysplastic nodules on Gd-EOB-DTPA MRI in patients with cirrhosis: a new diagnostic algorithm. Gut 67:1674–1682CrossRefPubMed Renzulli M, Biselli M, Brocchi S et al (2018) New hallmark of hepatocellular carcinoma, early hepatocellular carcinoma and high-grade dysplastic nodules on Gd-EOB-DTPA MRI in patients with cirrhosis: a new diagnostic algorithm. Gut 67:1674–1682CrossRefPubMed
29.
Zurück zum Zitat Byrnes V, Shi H, Kiryu S, Rofsky NM, Afdhal NH (2007) The clinical outcome of small (<20 mm) arterially enhancing nodules on MRI in the cirrhotic liver. Am J Gastroenterol 102:1654–1659CrossRefPubMed Byrnes V, Shi H, Kiryu S, Rofsky NM, Afdhal NH (2007) The clinical outcome of small (<20 mm) arterially enhancing nodules on MRI in the cirrhotic liver. Am J Gastroenterol 102:1654–1659CrossRefPubMed
30.
Zurück zum Zitat Park CJ, An C, Park S, Choi JY, Kim MJ (2018) Management of subcentimetre arterially enhancing and hepatobiliary hypointense lesions on gadoxetic acid-enhanced MRI in patients at risk for HCC. Eur Radiol 28:1476–1484CrossRefPubMed Park CJ, An C, Park S, Choi JY, Kim MJ (2018) Management of subcentimetre arterially enhancing and hepatobiliary hypointense lesions on gadoxetic acid-enhanced MRI in patients at risk for HCC. Eur Radiol 28:1476–1484CrossRefPubMed
31.
Zurück zum Zitat Kim JE, Kim SH, Lee SJ, Rhim H (2011) Hypervascular hepatocellular carcinoma 1 cm or smaller in patients with chronic liver disease: characterization with gadoxetic acid-enhanced MRI that includes diffusion-weighted imaging. AJR Am J Roentgenol 196:W758–W765CrossRefPubMed Kim JE, Kim SH, Lee SJ, Rhim H (2011) Hypervascular hepatocellular carcinoma 1 cm or smaller in patients with chronic liver disease: characterization with gadoxetic acid-enhanced MRI that includes diffusion-weighted imaging. AJR Am J Roentgenol 196:W758–W765CrossRefPubMed
32.
Zurück zum Zitat Lee SC, Chung HW, Chung JB et al (2002) Total necrosis of hepatocellular carcinoma due to spontaneous occlusion of feeding artery. Yonsei Med J 43:123–127CrossRefPubMed Lee SC, Chung HW, Chung JB et al (2002) Total necrosis of hepatocellular carcinoma due to spontaneous occlusion of feeding artery. Yonsei Med J 43:123–127CrossRefPubMed
33.
Zurück zum Zitat Del Poggio P, Mattiello M, Gilardoni L, Jamoletti C, Colombo S, Zabbialini G (2009) The mysterious case of spontaneous disappearance of hepatocellular carcinoma. Dig Liver Dis 41:e21–e25CrossRefPubMed Del Poggio P, Mattiello M, Gilardoni L, Jamoletti C, Colombo S, Zabbialini G (2009) The mysterious case of spontaneous disappearance of hepatocellular carcinoma. Dig Liver Dis 41:e21–e25CrossRefPubMed
34.
Zurück zum Zitat Matsuoka S, Tamura A, Moriyama M et al (2015) Pathological evidence of the cause of spontaneous regression in a case of resected hepatocellular carcinoma. Intern Med 54:25–30CrossRefPubMed Matsuoka S, Tamura A, Moriyama M et al (2015) Pathological evidence of the cause of spontaneous regression in a case of resected hepatocellular carcinoma. Intern Med 54:25–30CrossRefPubMed
35.
Zurück zum Zitat Bhardwaj N, Li M, Price T, Maddern GJ (2014) Spontaneous regression of a biopsy confirmed hepatocellular carcinoma. BMJ Case Rep 2014 Bhardwaj N, Li M, Price T, Maddern GJ (2014) Spontaneous regression of a biopsy confirmed hepatocellular carcinoma. BMJ Case Rep 2014
36.
Zurück zum Zitat Brunt E, Aishima S, Clavien PA et al (2018) cHCC-CCA: consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentiation. Hepatology 68:113–126CrossRefPubMed Brunt E, Aishima S, Clavien PA et al (2018) cHCC-CCA: consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentiation. Hepatology 68:113–126CrossRefPubMed
37.
Zurück zum Zitat Fraum TJ, Tsai R, Rohe E et al (2018) Differentiation of hepatocellular carcinoma from other hepatic malignancies in patients at risk: diagnostic performance of the Liver Imaging Reporting and Data System version 2014. Radiology 286:158–172CrossRefPubMed Fraum TJ, Tsai R, Rohe E et al (2018) Differentiation of hepatocellular carcinoma from other hepatic malignancies in patients at risk: diagnostic performance of the Liver Imaging Reporting and Data System version 2014. Radiology 286:158–172CrossRefPubMed
38.
Zurück zum Zitat Kim YY, An C, Kim S, Kim MJ (2018) Diagnostic accuracy of prospective application of the Liver Imaging Reporting and Data System (LI-RADS) in gadoxetate-enhanced MRI. Eur Radiol 28:2038–2046CrossRefPubMed Kim YY, An C, Kim S, Kim MJ (2018) Diagnostic accuracy of prospective application of the Liver Imaging Reporting and Data System (LI-RADS) in gadoxetate-enhanced MRI. Eur Radiol 28:2038–2046CrossRefPubMed
39.
Zurück zum Zitat Potretzke TA, Tan BR, Doyle MB, Brunt EM, Heiken JP, Fowler KJ (2016) Imaging features of biphenotypic primary liver carcinoma (hepatocholangiocarcinoma) and the potential to mimic hepatocellular carcinoma: LI-RADS analysis of CT and MRI features in 61 cases. AJR Am J Roentgenol 207:25–31CrossRefPubMed Potretzke TA, Tan BR, Doyle MB, Brunt EM, Heiken JP, Fowler KJ (2016) Imaging features of biphenotypic primary liver carcinoma (hepatocholangiocarcinoma) and the potential to mimic hepatocellular carcinoma: LI-RADS analysis of CT and MRI features in 61 cases. AJR Am J Roentgenol 207:25–31CrossRefPubMed
42.
Zurück zum Zitat Rogers JE, Bolonesi RM, Rashid A et al (2017) Systemic therapy for unresectable, mixed hepatocellular-cholangiocarcinoma: treatment of a rare malignancy. J Gastrointest Oncol 8:347–351CrossRefPubMedPubMedCentral Rogers JE, Bolonesi RM, Rashid A et al (2017) Systemic therapy for unresectable, mixed hepatocellular-cholangiocarcinoma: treatment of a rare malignancy. J Gastrointest Oncol 8:347–351CrossRefPubMedPubMedCentral
43.
Zurück zum Zitat Lunsford KE, Court C, Seok Lee Y et al (2018) Propensity-matched analysis of patients with mixed hepatocellular-cholangiocarcinoma and hepatocellular carcinoma undergoing liver transplantation. Liver Transpl 24:1384–1397CrossRefPubMed Lunsford KE, Court C, Seok Lee Y et al (2018) Propensity-matched analysis of patients with mixed hepatocellular-cholangiocarcinoma and hepatocellular carcinoma undergoing liver transplantation. Liver Transpl 24:1384–1397CrossRefPubMed
44.
Zurück zum Zitat Choi SH, Lee SS, Kim SY et al (2017) Intrahepatic cholangiocarcinoma in patients with cirrhosis: differentiation from hepatocellular carcinoma by using gadoxetic acid-enhanced MR imaging and dynamic CT. Radiology 282:771–781CrossRefPubMed Choi SH, Lee SS, Kim SY et al (2017) Intrahepatic cholangiocarcinoma in patients with cirrhosis: differentiation from hepatocellular carcinoma by using gadoxetic acid-enhanced MR imaging and dynamic CT. Radiology 282:771–781CrossRefPubMed
45.
Zurück zum Zitat Huang B, Wu L, Lu XY et al (2016) Small intrahepatic cholangiocarcinoma and hepatocellular carcinoma in cirrhotic livers may share similar enhancement patterns at multiphase dynamic MR imaging. Radiology 281:150–157CrossRefPubMed Huang B, Wu L, Lu XY et al (2016) Small intrahepatic cholangiocarcinoma and hepatocellular carcinoma in cirrhotic livers may share similar enhancement patterns at multiphase dynamic MR imaging. Radiology 281:150–157CrossRefPubMed
46.
Zurück zum Zitat Chung YE, Kim MJ, Park YN et al (2009) Varying appearances of cholangiocarcinoma: radiologic-pathologic correlation. Radiographics 29:683–700CrossRefPubMed Chung YE, Kim MJ, Park YN et al (2009) Varying appearances of cholangiocarcinoma: radiologic-pathologic correlation. Radiographics 29:683–700CrossRefPubMed
47.
Zurück zum Zitat Xu J, Igarashi S, Sasaki M et al (2012) Intrahepatic cholangiocarcinomas in cirrhosis are hypervascular in comparison with those in normal livers. Liver Int 32:1156–1164CrossRefPubMed Xu J, Igarashi S, Sasaki M et al (2012) Intrahepatic cholangiocarcinomas in cirrhosis are hypervascular in comparison with those in normal livers. Liver Int 32:1156–1164CrossRefPubMed
48.
Zurück zum Zitat Sheng RF, Zeng MS, Rao SX, Ji Y, Chen LL (2014) MRI of small intrahepatic mass-forming cholangiocarcinoma and atypical small hepatocellular carcinoma (≤3 cm) with cirrhosis and chronic viral hepatitis: a comparative study. Clin Imaging 38:265–272 Sheng RF, Zeng MS, Rao SX, Ji Y, Chen LL (2014) MRI of small intrahepatic mass-forming cholangiocarcinoma and atypical small hepatocellular carcinoma (≤3 cm) with cirrhosis and chronic viral hepatitis: a comparative study. Clin Imaging 38:265–272
49.
Zurück zum Zitat Kim SA, Lee JM, Lee KB et al (2011) Intrahepatic mass-forming cholangiocarcinomas: enhancement patterns at multiphasic CT, with special emphasis on arterial enhancement pattern--correlation with clinicopathologic findings. Radiology 260:148–157CrossRefPubMed Kim SA, Lee JM, Lee KB et al (2011) Intrahepatic mass-forming cholangiocarcinomas: enhancement patterns at multiphasic CT, with special emphasis on arterial enhancement pattern--correlation with clinicopathologic findings. Radiology 260:148–157CrossRefPubMed
50.
Zurück zum Zitat Jeong HT, Kim MJ, Chung YE, Choi JY, Park YN, Kim KW (2013) Gadoxetate disodium-enhanced MRI of mass-forming intrahepatic cholangiocarcinomas: imaging-histologic correlation. AJR Am J Roentgenol 201:W603–W611CrossRefPubMed Jeong HT, Kim MJ, Chung YE, Choi JY, Park YN, Kim KW (2013) Gadoxetate disodium-enhanced MRI of mass-forming intrahepatic cholangiocarcinomas: imaging-histologic correlation. AJR Am J Roentgenol 201:W603–W611CrossRefPubMed
51.
Zurück zum Zitat Fujita N, Asayama Y, Nishie A et al (2017) Mass-forming intrahepatic cholangiocarcinoma: enhancement patterns in the arterial phase of dynamic hepatic CT - correlation with clinicopathological findings. Eur Radiol 27:498–506CrossRefPubMed Fujita N, Asayama Y, Nishie A et al (2017) Mass-forming intrahepatic cholangiocarcinoma: enhancement patterns in the arterial phase of dynamic hepatic CT - correlation with clinicopathological findings. Eur Radiol 27:498–506CrossRefPubMed
52.
Zurück zum Zitat Nanashima A, Abo T, Murakami G et al (2013) Intrahepatic cholangiocarcinoma: relationship between tumor imaging enhancement by measuring attenuation and clinicopathologic characteristics. Abdom Imaging 38:785–792CrossRefPubMed Nanashima A, Abo T, Murakami G et al (2013) Intrahepatic cholangiocarcinoma: relationship between tumor imaging enhancement by measuring attenuation and clinicopathologic characteristics. Abdom Imaging 38:785–792CrossRefPubMed
54.
Zurück zum Zitat Torbenson MS (2017) Morphologic subtypes of hepatocellular carcinoma. Gastroenterol Clin North Am 46:365–391CrossRefPubMed Torbenson MS (2017) Morphologic subtypes of hepatocellular carcinoma. Gastroenterol Clin North Am 46:365–391CrossRefPubMed
55.
Zurück zum Zitat Gu KW, Kim YK, Min JH, Ha SY, Jeong WK (2017) Imaging features of hepatic sarcomatous carcinoma on computed tomography and gadoxetic acid-enhanced magnetic resonance imaging. Abdom Radiol (NY) 42:1424–1433CrossRef Gu KW, Kim YK, Min JH, Ha SY, Jeong WK (2017) Imaging features of hepatic sarcomatous carcinoma on computed tomography and gadoxetic acid-enhanced magnetic resonance imaging. Abdom Radiol (NY) 42:1424–1433CrossRef
56.
Zurück zum Zitat Pua U, Low SC, Tan YM, Lim KH (2009) Combined hepatocellular and cholangiocarcinoma with sarcomatoid transformation: radiologic-pathologic correlation of a case. Hepatol Int 3:587–592CrossRefPubMedPubMedCentral Pua U, Low SC, Tan YM, Lim KH (2009) Combined hepatocellular and cholangiocarcinoma with sarcomatoid transformation: radiologic-pathologic correlation of a case. Hepatol Int 3:587–592CrossRefPubMedPubMedCentral
57.
Zurück zum Zitat Koo HR, Park MS, Kim MJ et al (2008) Radiological and clinical features of sarcomatoid hepatocellular carcinoma in 11 cases. J Comput Assist Tomogr 32:745–749CrossRefPubMed Koo HR, Park MS, Kim MJ et al (2008) Radiological and clinical features of sarcomatoid hepatocellular carcinoma in 11 cases. J Comput Assist Tomogr 32:745–749CrossRefPubMed
58.
Zurück zum Zitat Honda H, Hayashi T, Yoshida K et al (1996) Hepatocellular carcinoma with sarcomatous change: characteristic findings of two-phased incremental CT. Abdom Imaging 21:37–40CrossRefPubMed Honda H, Hayashi T, Yoshida K et al (1996) Hepatocellular carcinoma with sarcomatous change: characteristic findings of two-phased incremental CT. Abdom Imaging 21:37–40CrossRefPubMed
60.
Zurück zum Zitat Labgaa I, Stueck A, Ward SC (2017) Lymphoepithelioma-like carcinoma in liver. Am J Pathol 187:1438–1444CrossRefPubMed Labgaa I, Stueck A, Ward SC (2017) Lymphoepithelioma-like carcinoma in liver. Am J Pathol 187:1438–1444CrossRefPubMed
61.
Zurück zum Zitat Chan AW, Tong JH, Pan Y et al (2015) Lymphoepithelioma-like hepatocellular carcinoma: an uncommon variant of hepatocellular carcinoma with favorable outcome. Am J Surg Pathol 39:304–312CrossRefPubMed Chan AW, Tong JH, Pan Y et al (2015) Lymphoepithelioma-like hepatocellular carcinoma: an uncommon variant of hepatocellular carcinoma with favorable outcome. Am J Surg Pathol 39:304–312CrossRefPubMed
62.
Zurück zum Zitat Cacciato Insilla A, Faviana P, Pollina LE et al (2015) Lymphoepithelioma-like hepatocellular carcinoma: case report and review of the literature. World J Gastroenterol 21:10468–10474CrossRefPubMedPubMedCentral Cacciato Insilla A, Faviana P, Pollina LE et al (2015) Lymphoepithelioma-like hepatocellular carcinoma: case report and review of the literature. World J Gastroenterol 21:10468–10474CrossRefPubMedPubMedCentral
63.
Zurück zum Zitat Kim YC, Park MS, Chung YE et al (2010) MRI findings of uncommon non-hepatocyte origin primary liver tumours with pathological correlation. Br J Radiol 83:1080–1086CrossRefPubMedPubMedCentral Kim YC, Park MS, Chung YE et al (2010) MRI findings of uncommon non-hepatocyte origin primary liver tumours with pathological correlation. Br J Radiol 83:1080–1086CrossRefPubMedPubMedCentral
64.
Zurück zum Zitat Liao TC, Liu CA, Chiu NC, Yeh YC, Chiou YY (2015) Lymphoepithelioma-like cholangiocarcinoma: a mimic of hepatocellular carcinoma on imaging features. World J Gastroenterol 21:4089–4095CrossRefPubMedPubMedCentral Liao TC, Liu CA, Chiu NC, Yeh YC, Chiou YY (2015) Lymphoepithelioma-like cholangiocarcinoma: a mimic of hepatocellular carcinoma on imaging features. World J Gastroenterol 21:4089–4095CrossRefPubMedPubMedCentral
65.
Zurück zum Zitat Lee H, Yoon JH, Kim H et al (2017) False positive diagnosis of hepatocellular carcinoma in liver resection patients. J Korean Med Sci 32:315–320CrossRefPubMed Lee H, Yoon JH, Kim H et al (2017) False positive diagnosis of hepatocellular carcinoma in liver resection patients. J Korean Med Sci 32:315–320CrossRefPubMed
66.
Zurück zum Zitat Rougemont AL, McLin VA, Toso C, Wildhaber BE (2012) Adult hepatoblastoma: learning from children. J Hepatol 56:1392–1403CrossRefPubMed Rougemont AL, McLin VA, Toso C, Wildhaber BE (2012) Adult hepatoblastoma: learning from children. J Hepatol 56:1392–1403CrossRefPubMed
67.
68.
Zurück zum Zitat Roth CG, Mitchell DG (2014) Hepatocellular carcinoma and other hepatic malignancies: MR imaging. Radiol Clin N Am 52:683–707CrossRefPubMed Roth CG, Mitchell DG (2014) Hepatocellular carcinoma and other hepatic malignancies: MR imaging. Radiol Clin N Am 52:683–707CrossRefPubMed
69.
Zurück zum Zitat Tan Y, Xiao EH (2013) Rare hepatic malignant tumors: dynamic CT, MRI, and clinicopathologic features: with analysis of 54 cases and review of the literature. Abdom Imaging 38:511–526CrossRefPubMed Tan Y, Xiao EH (2013) Rare hepatic malignant tumors: dynamic CT, MRI, and clinicopathologic features: with analysis of 54 cases and review of the literature. Abdom Imaging 38:511–526CrossRefPubMed
70.
Zurück zum Zitat An C, Park S, Choi YJ (2013) Diffusion-weighted MRI in intrahepatic bile duct adenoma arising from the cirrhotic liver. Korean J Radiol 14:769–775CrossRefPubMedPubMedCentral An C, Park S, Choi YJ (2013) Diffusion-weighted MRI in intrahepatic bile duct adenoma arising from the cirrhotic liver. Korean J Radiol 14:769–775CrossRefPubMedPubMedCentral
71.
Zurück zum Zitat Chen CB, Chou CT, Hsueh C, Lee KW, Chen YL (2013) Hepatic inflammatory pseudotumor mimicking hepatocellular carcinoma. J Chin Med Assoc 76:299–301CrossRefPubMed Chen CB, Chou CT, Hsueh C, Lee KW, Chen YL (2013) Hepatic inflammatory pseudotumor mimicking hepatocellular carcinoma. J Chin Med Assoc 76:299–301CrossRefPubMed
72.
Zurück zum Zitat Kim JW, Shin SS, Heo SH, Lim HS, Hur YH, Kim JH (2013) Hepatic abscess mimicking hepatocellular carcinoma in a patient with alcoholic liver disease. Clin Mol Hepatol 19:431–434CrossRefPubMedPubMedCentral Kim JW, Shin SS, Heo SH, Lim HS, Hur YH, Kim JH (2013) Hepatic abscess mimicking hepatocellular carcinoma in a patient with alcoholic liver disease. Clin Mol Hepatol 19:431–434CrossRefPubMedPubMedCentral
73.
Zurück zum Zitat Kleiner DE (2018) Hepatocellular carcinoma: liver biopsy in the balance. Hepatology 68:13–15CrossRefPubMed Kleiner DE (2018) Hepatocellular carcinoma: liver biopsy in the balance. Hepatology 68:13–15CrossRefPubMed
Metadaten
Titel
Problematic lesions in cirrhotic liver mimicking hepatocellular carcinoma
verfasst von
Myeong-Jin Kim
Sunyoung Lee
Chansik An
Publikationsdatum
20.02.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 9/2019
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-019-06030-0

Weitere Artikel der Ausgabe 9/2019

European Radiology 9/2019 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.